{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:32:54Z","timestamp":1790274774959,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jacc.2016.03.512","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T01:28:37Z","timestamp":1459301317000},"page":"1116-1139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary\u00a0Artery Disease"],"prefix":"10.1016","volume":"68","author":[{"given":"John A.","family":"Bittl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duminda N.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.03.512_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guidelines for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.03.512_bib7","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2011.06.049","article-title":"Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials","volume":"58","author":"Baber","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"Camenzind","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib14","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib15","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib18","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.03.512_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet\u00a0treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib20","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.03.512_bib23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual-antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib24","first-page":"365","article-title":"Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial","volume":"37","author":"Helft","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.03.512_bib25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib26","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.jacc.2016.03.512_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2012.09.025","article-title":"ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on\u00a0Practice Guidelines","volume":"61","author":"Jacobs","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib28","series-title":"Bayesian Approaches to Clinical Trials and Health Care Evaluations","author":"Spiegelhalter","year":"2004"},{"key":"10.1016\/j.jacc.2016.03.512_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jama.2015.1671","article-title":"Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the Dual Antiplatelet Therapy randomized clinical trial","volume":"313","author":"Kereiakes","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.03.512_bib30","series-title":"Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison","first-page":"285","article-title":"Case study in cardiovascular medicine: unprotected left main coronary artery disease","author":"He","year":"2014"},{"key":"10.1016\/j.jacc.2016.03.512_bib31","series-title":"Bayesian Methods for Data Analysis","author":"Carlin","year":"2009"},{"key":"10.1016\/j.jacc.2016.03.512_bib32","series-title":"Doing Bayesian Data Analysis: A Tutorial With R and BUGS","author":"Kruschke","year":"2010"},{"key":"10.1016\/j.jacc.2016.03.512_bib33","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib34","unstructured":"Schwarzer G.Package \u2018meta\u2019. Freiburg, Germany: version 3.8-0,\u00a02012."},{"key":"10.1016\/j.jacc.2016.03.512_bib35","series-title":"The BUGS Book: A Practical Introduction to Bayesian Analysis","author":"Lunn","year":"2013"},{"key":"10.1016\/j.jacc.2016.03.512_bib36","first-page":"12","article-title":"Making BUGS open","author":"Thomas","year":"2006","journal-title":"R\u00a0News"},{"key":"10.1016\/j.jacc.2016.03.512_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-1","article-title":"Simpson\u2019s paradox and calculation of number needed to treat from meta-analysis","volume":"2","author":"Cates","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2016.03.512_bib38","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2015.06.1338","article-title":"Dual-antiplatelet therapy for diabetic patients after stent implantation: lessons from an observational study","volume":"66","author":"Bittl","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib39","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib40","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/01.CIR.89.6.2892","article-title":"The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib41","series-title":"Clinical Trials: A Methodologic Perspective","first-page":"230","article-title":"Stopping considerations","author":"Piantadosi","year":"1997"},{"key":"10.1016\/j.jacc.2016.03.512_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib43","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","article-title":"Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction","volume":"65","author":"Yeh","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib44","first-page":"390","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with\u00a0previous myocardial infarction: a collaborative meta-analysis of randomized trials","volume":"37","author":"Udell","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.03.512_bib45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0140-6736(14)62052-3","article-title":"Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis (erratum in Lancet. 2015;355;1834)","volume":"385","author":"Elmariah","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib46","unstructured":"US Food and Drug Administration. (November 6, 2015) Plavix (clopidogrel): drug safety communication\u2014long-term treatment does not change risk of death. Available at: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducs\/ucm471531.htm. Accessed February 24,\u00a02016."},{"key":"10.1016\/j.jacc.2016.03.512_bib47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation","volume":"99","author":"Moussa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib49","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.03.512_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.03.512_bib51","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/CIRCULATIONAHA.112.102335","article-title":"Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation","volume":"125","author":"Kleiman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.111.078923","article-title":"No one-size-fits-all: a tailored approach to antithrombotic therapy after stent implantation","volume":"125","author":"Pfisterer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.03.512_bib53","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jacc.2012.08.003","article-title":"Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?","volume":"60","author":"Witzenbichler","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib54","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jacc.2014.09.007","article-title":"Art and science","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib55","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMe1413297","article-title":"Dual antiplatelet therapy after drug-eluting stents-how long to treat?","volume":"371","author":"Colombo","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib56","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehv103","article-title":"Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?","volume":"36","author":"Binder","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.03.512_bib57","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1056\/NEJMe1502137","article-title":"Balancing the risks and benefits of dual platelet inhibition","volume":"372","author":"Keaney","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib58","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2004.01.035","article-title":"Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials","volume":"43","author":"Diamond","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7326\/0003-4819-130-12-199906150-00008","article-title":"Toward evidence-based medical statistics. 1: the P value fallacy","volume":"130","author":"Goodman","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib60","series-title":"Clinical Trials: Design, Conduct, and Analysis","first-page":"159","article-title":"Patient follow-up, close-out, and post-trial follow-up","author":"Meinert","year":"1986"},{"key":"10.1016\/j.jacc.2016.03.512_bib61","series-title":"Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison","first-page":"3","article-title":"The hierarchy of evidence","author":"Morey-Vargas","year":"2014"},{"key":"10.1016\/j.jacc.2016.03.512_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-0083","article-title":"Longer-versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis","volume":"163","author":"Spencer","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib63","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2016.03.512_bib64","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","article-title":"Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence","volume":"66","author":"Montalescot","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.03.512_bib65","series-title":"Clinical Trials: Design, Conduct, and Analysis","first-page":"196","article-title":"Questions concerning the design, analysis, and interpretation of clinical trials","author":"Meinert","year":"1986"},{"key":"10.1016\/j.jacc.2016.03.512_bib66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","article-title":"Stent thrombosis: a clinical perspective","volume":"7","author":"Claessen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.03.512_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.109.852178.109.852178","article-title":"Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries","volume":"2","author":"Lasala","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2016.03.512_bib68","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcin.2015.10.001","article-title":"Benefits and risks of extended dual antiplatelet therapy after everolimus-eluting stents","volume":"9","author":"Hermiller","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.03.512_bib69","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for mycocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.03.512_bib72","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2016.07.726","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716016983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716016983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T07:17:47Z","timestamp":1597821467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716016983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0735109716016983"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.03.512","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary\u00a0Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.03.512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation and the American Heart Association, Inc.","name":"copyright","label":"Copyright"}]}}